The non-gynaecological cytology service of Central Manchester
University Hospitals NHS Foundation Trust (CMFT) is located on the
1st Floor of the Clinical Sciences Building 2.
We report approximately 3,500 samples per annum and offer a
comprehensive specialist service, reporting on a wide range of
samples including serous fluids, urine, cerebrospinal fluid,
bronchoscopically obtained respiratory samples and fine needle
FNAs are taken from a wide variety of sites including thyroid,
lymph nodes, salivary glands, and deep tissues and organs, and may
be performed freehand, under radiological guidance or by endoscopic
ultrasound (EUS) and endobronchial ultrasound (EBUS).
We are staffed by approximately 3.15 WTE consultant
cytopathologists, 6.0 WTE BMS with MLA support and provide a
diagnostic service to CMFT, Trafford General Hospital, the Christie
Hospital, other NHS Trusts, private care sector providers and
We have a consultant led service which provides on-site
provisional diagnosis at EBUS clinics and BMS assistance at a wide
range of FNA clinics, including adequacy assessment at head and
neck clinics at CMFT and Trafford General Hospital as well as all
types of clinics at the Christie Hospital.
The department serves many specialised services at CMFT
including gynaecological, respiratory, head and neck, urological
and hepatopancreaticobiliary diagnostic services. This unique
department is at the forefront of personalised medicine due to our
close working relationship with the Manchester Centre for Genomic
Medicine based at CMFT and preparation of a wide range of
non-gynaecological cytology samples for molecular testing.
The NG cytology department is fully CPA accredited and is an
IBMS approved training centre. We are closely associated with The
North of England Pathology and Screening Educational Centre
(NEPSEC) and provide training to medics and scientific staff and
are fully committed to maintaining this accreditation by an
established quality management system and standards determined by
the Royal College of Pathologists together, with scheduled clinical
and quality audits and national guidelines. We are working towards
full ISO 15189:2012 accreditation.
Reports generated by the Department of Cellular Pathology
including Cytopathology are, in the main, qualitative rather than
quantitative. Uncertainty of Measurement is considered and
controlled throughout the sample pathway by employment of a robust
quality management system and continued accreditation to national
standards. Where direct clinical impact measurements are made,
assessments of uncertainty of measurement are made and are
available on request.
The laboratory adheres to Central Manchester University Hospital
Foundation Trust's policies on data protection and disclosure. In
addition the Trust also produces a patient
information leaflet entitled "Your Information".
(Last updated April 21st 2016)